Global Psychiatric Association
  • Register
  • Login

GLOBAL PSYCHIATRY ARCHIVES

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 5, Issue 1
  3. Authors

Online ISSN: 2754-9380

Volume5, Issue1

Monitoring the Adverse Effects of Psychotropic drugs – Need for An Evidence-Based Approach

    Sumeet Gupta Udayan Khastgir Ogba Onwuchekwa Ioana Varvari

GLOBAL PSYCHIATRY ARCHIVES, 2022, Volume 5, Issue 1, Pages 51-63
10.52095/gpa.2022.4362.1034

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Psychotropic drugs are associated with adverse effects. Mostly adverse effects are reported by patients or elicited by clinicians. For many other adverse effects, it is necessary to do baseline blood tests to avoid giving a medication to patients who are at a high risk of a particular adverse effects and to monitor blood tests to either avoid or to manage specific adverse effects. Most treatment guidelines recommend blood tests to monitor adverse effects of psychotropic drugs. However, mostly these recommendations are based on low levels of scientific evidence and expert opinions. Hence, it is not uncommon to see significant variations amongst different guidelines. Ideally, the monitoring recommendations should take in to account clinical significance and pathophysiology of the adverse effects. Moreover, before proposing any form of monitoring, we must be reasonably sure that such monitoring will be beneficial for patients and lastly monitoring should be cost effective as well. In the field of medicine, monitoring recommendations are increasingly subjected to scientific rigour. In this review, we have compared blood tests monitoring recommendations, by various national and international treatment guidelines, of commonly used psychotropic drugs such as antipsychotic drugs, lithium, and valproate. This is a narrative review, in which we have critically appraised the recommendations and highlighted the need for evidence-based monitoring of adverse effects of psychotropic drugs.
Keywords:
    Psychotropic drug,, ,،,؛Monitoring,, ,،,؛Physical health,, ,،,؛Evidence based medicine,, ,،,؛NICE guidelines,, ,،,؛Antipsychotics,, ,،,؛Lithium,, ,،,؛Valproate
Main Subjects:
  • General psychiatry
  • PDF (348 K)
  • XML
(2022). Monitoring the Adverse Effects of Psychotropic drugs – Need for An Evidence-Based Approach. GLOBAL PSYCHIATRY ARCHIVES, 5(1), 51-63. doi: 10.52095/gpa.2022.4362.1034
Sumeet Gupta; Udayan Khastgir; Ogba Onwuchekwa; Ioana Varvari. "Monitoring the Adverse Effects of Psychotropic drugs – Need for An Evidence-Based Approach". GLOBAL PSYCHIATRY ARCHIVES, 5, 1, 2022, 51-63. doi: 10.52095/gpa.2022.4362.1034
(2022). 'Monitoring the Adverse Effects of Psychotropic drugs – Need for An Evidence-Based Approach', GLOBAL PSYCHIATRY ARCHIVES, 5(1), pp. 51-63. doi: 10.52095/gpa.2022.4362.1034
Monitoring the Adverse Effects of Psychotropic drugs – Need for An Evidence-Based Approach. GLOBAL PSYCHIATRY ARCHIVES, 2022; 5(1): 51-63. doi: 10.52095/gpa.2022.4362.1034
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 105
  • PDF Download: 36
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher: Global Psychiatric Association

Email:  globalpsychiatry@gmx.com

Editor-in-chief: Professor Christopher Paul Szabo

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap
This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus